NMPA Approval

Duvelisib Capsules

Approval Number

国药准字HJ20220018

Registration Date

March 16, 2022

Drug Information

Generic Name

度维利塞胶囊

Trade Name

克必妥

Dosage Form

胶囊剂

Strength

25mg

Drug Type

化学药品

Registration Date

March 16, 2022

Expiry Date

March 15, 2027

Company Address

1995 Village Center Circle, Suite 128, Las Vegas, NV 89134 United States of America

Company Address

10245 Hickman Mills Drive, Kansas City, MO 64137 United States of America

Empowering clinical research with data-driven insights and AI-powered tools.

度维利塞胶囊 - NMPA 批准文号 | MedPath